J&J slashes April target of vaccine

With domestic production of the company’s vaccine still unapproved, the government slashed its national allocation of the J&J vaccine to states by 86 percent to just 700,000 doses next week, down from nearly 5 million, a cut that Maryland Gov. Larry Hogan (R) called “very concerning.”